Home
Orbimed Advisors, 10% Owner: Passage BIO PASG Sell · Filed 25/01/14
Trade details
- Type
- Insider sale
- Amount
- $83,297.94
- Shares · price
- 126,209 sh · $0.66 a share
- Held after
- 7,131,636 sh
- Stock
- Passage BIO PASG
- Trade date
- 25/01/10
- Filed
- 25/01/14
- Days to filing
- 4 days
Sold 1.7% of holdings
- Share of holding sold
- 1.7%
Passage BIO trades, last 26 weeks
What else happened in Passage BIO around then
Filed or reported within 30 days of the trade day · 24/12/11~25/02/09Orbimed Advisors's recent trades
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21